Physician profile

Alexandra Simotas

Obstetrics & Gynecology · Houston, TX

NPI 1528035656

$471.45

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$268.60

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Hologic Sales and Service, LLC $82.18 2019-2021
Pfizer INC. $72.03 2023-2024
Mayne Pharma Commercial LLC $68.43 2023-2024
Agile Therapeutics, INC. $44.53 2021-2024 Twirla
Abbvie INC. $44.17 2020-2024
Therapeuticsmd, INC. $42.22 2019-2021
Astellas Pharma US INC $38.41 2023 Veozah
Aspira Women'S Health INC $35.23 2024 Ova1
Smith+Nephew, INC. $15.74 2019
Exeltis, USA INC. $14.92 2019
Allergan, INC. $13.59 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Alexandra Simotas

$471.45

in general payments reported 2019-2025

Years
2019-2024
Top company
Hologic Sales and Service, LLC

https://glasscript.com/doctor/68445/alexandra-simotas

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.